Genome-wide Association Study of Survival in Early-stage Non-Small Cell Lung Cancer

Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study

(2012) Youngjoo Lee et al.   CARCINOGENESIS

Genome-Wide Association Study of Prognosis in Advanced Non-Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy

(2012) L. Hu et al.   CLINICAL CANCER RESEARCH

Common genetic variants in cell cycle pathway are associated with survival in stage III–IV non-small-cell lung cancer

(2011) Jikai Yin et al.   CARCINOGENESIS

Genome-Wide Association Study of Survival in Non–Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy

(2011) Xifeng Wu et al.   JNCI-Journal of the National Cancer Institute

A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese

(2011) Zhibin Hu et al.   NATURE GENETICS

Genome-Wide Association Study on Overall Survival of Advanced Non-small Cell Lung Cancer Patients Treated with Carboplatin and Paclitaxel

(2010) Yasunori Sato et al.   Journal of Thoracic Oncology

Genotype Imputation

(2009) Yun Li et al.   Annual Review of Genomics and Human Genetics

Genome-Wide Analysis of Survival in Early-Stage Non–Small-Cell Lung Cancer

(2009) Yen-Tsung Huang et al.   JOURNAL OF CLINICAL ONCOLOGY

Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

(2008) Kerby Shedden et al.   NATURE MEDICINE

Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy

(2008) Xifeng Wu et al.   Pharmacogenetics and Genomics